European Society Of Cardiology/European Atherosclerosis Society Task Force Consensus Statement On Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Practical Guidance For Use In Patients At Very High Cardiovascular Risk

View/Open
Date
2017
Author
Landmesser, Ulf
Chapman, M. John
Farnier, Michel
Gencer, Baris
Gielen, Stephan
Hovingh, G. Kees
Luscher, Thomas F.
Sinning, David
Tokgozoglu, Lale
Wiklund, Olov
Luis Zamorano, Jose
Pinto, Fausto J.
Catapano, Alberico L.
xmlui.mirage2.itemSummaryView.MetaData
Show full item record
URI
https://doi.org/10.1093/eurheartj/ehw480
http://hdl.handle.net/11655/15521
xmlui.mirage2.itemSummaryView.Collections